secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senseonics Holdings, Inc. (SENS)
CIK:        0001616543
Form:       8-K
Filed at:   2023-01-10T23:59:59+00:00
Accession:  0001104659-23-002763
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Senseonics adopts 2023 Commercial Equity Plan for partner Ascensia employees; up to 10M shares
--------------------------------------------------------------------------------

- Board adopted 2023 Commercial Equity Plan on Jan 10, 2023 to grant stock options and RSUs to employees of commercial partner Ascensia Diabetes Care.
- Plan reserves 10,000,000 shares of common stock for issuance, subject to performance-based vesting.
- Grants require SEC Form S-3 registration statement to be declared effective before awards can be issued.
- Plan aims to align incentives of individuals supporting Eversense commercialization with shareholder interests.
- Eligible recipients include Ascensia employees assisting with commercialization, who are ineligible for the existing 2015 Equity Incentive Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1616543/000110465923002763/0001104659-23-002763-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1616543/000110465923002763/tm232916d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-002763

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer